Nexalin (NXL) Director Acquires 83,333 Shares — Form 4 Update
Nexalin Technology, Inc. (NXL) Form 4 shows Director Leonard Osser (with spouse Marilyn Elson) reported a non-derivative acquisition of 83,333 common shares on 09/29/2025 at a recorded price of $0.
Rhea-AI Filing Summary
Nexalin Technology, Inc. (NXL) Form 4 shows Director Leonard Osser (with spouse Marilyn Elson) reported a non-derivative acquisition of 83,333 common shares on 09/29/2025 at a recorded price of $0. After the transaction the reporting parties beneficially own 1,618,577 shares, held directly with shared voting and dispositive power between Mr. Osser and Ms. Elson. The filing is a joint ownership Form 4 and is signed by both reporting persons.
Positive
- Insider acquisition disclosed: 83,333 common shares acquired on 09/29/2025
- Clear ownership reporting: Combined direct beneficial ownership quantified at 1,618,577 shares
- Joint filing and signatures present: Form 4 signed by both reporting persons, indicating compliance with reporting rules
Negative
- None.
Insights
TL;DR: Director purchase recorded; modest incremental stake relative to total reported holdings and no price paid is noted.
The Form 4 documents a purchase of 83,333 common shares by Director Leonard Osser, with the reporting structure showing joint ownership with spouse Marilyn Elson. The filing records the transaction price as $0 and shows combined direct beneficial ownership of 1,618,577 shares after the trade. For investors, this transaction updates insider stake levels but does not on its face provide valuation context or indicate change in control. The absence of derivative activity and the direct ownership form simplify the ownership picture.
TL;DR: Governance update confirms insider ownership and shared voting power; filing appears routine.
The report clarifies that voting and dispositive powers over the reported shares are shared between Mr. Osser and Ms. Elson, and the Form 4 is filed as a joint ownership disclosure. Signatures from both reporting persons are present, satisfying Section 16 reporting formalities. The filing contains no derivative grants, option exercises, or departures that would signal governance shifts.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 83,333 | $0.00 | $0.00 |
Footnotes (1)
- F1. Includes shares that Reporting Person owns with spouse Leonard Osser and for which Reporting Person has shared voting and dispositive power with spouse. Form 4 filed as joint ownership filing
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transaction was reported on the Form 4 for Nexalin Technology (NXL)?
Who filed the Form 4 for NXL and what are their relationships to the company?
Was any derivative security activity (options, warrants) reported on this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.